Metabolic differences in breast cancer stem cells and differentiated progeny

Breast Cancer Research and Treatment

Volumn 146, Issue 3, 2014, Pages 525-534

  Vlashi, Erina ^a   Lagadec, Chann ^a   Vergnes, Laurent ^a   Reue, Karen ^a   Frohnen, Patricia ^a   Chan, Mabel ^a   Alhiyari, Yazeed ^a   Dratver, Milana Bochkur ^a   Pajonk, Frank ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer stem cells; Metabolism; Radiation

Indexed keywords

6 PHOSPHOFRUCTOKINASE; ADENOSINE TRIPHOSPHATE; GLUCOSE; LACTIC ACID;

ACIDIFICATION; ARTICLE; BREAST CANCER STEM CELL; CANCER STEM CELL; CELL DIFFERENTIATION; CELL METABOLISM; CELL POPULATION; CONTROLLED STUDY; EXTRACELLULAR SPACE; GLUCOSE INTAKE; HUMAN; HUMAN CELL; METABOLIC FLUX ANALYSIS; MITOCHONDRIAL CAPACITY; MITOCHONDRIAL PROTON LEAK; MITOCHONDRION; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; PHENOTYPE; PRIORITY JOURNAL; PROGENY; PROTEIN SYNTHESIS; UPREGULATION; BREAST TUMOR; FEMALE; GENETICS; GLYCOLYSIS; MCF 7 CELL LINE; METABOLISM; PATHOLOGY; RADIATION RESPONSE; X RAY;

BREAST NEOPLASMS; CELL DIFFERENTIATION; FEMALE; GLYCOLYSIS; HUMANS; MCF-7 CELLS; NEOPLASTIC STEM CELLS; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; X-RAYS;

EID: 84907598112     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-014-3051-2     Document Type: Article

References (27)

1. Overgaard M, Jensen MB, Overgaard J, Hansen PS, Rose C, Andersson M, Kamby C, Kjaer M, Gadeberg CC, Rasmussen BB et al (1999) Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 353(9165):1641-1648 (Pubitemid 29224519)
2. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, Godwin J, Gray R, Hicks C, James S et al (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366(9503):2087-2106 (Pubitemid 41797643)
3. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100:3983-3988 (Pubitemid 36418143)
4. Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414(6859):105-111 (Pubitemid 33041634)
5. Warburg O, Posener K, Negelein E (1924) Ueber den Stoffwechsel der Tumoren. Biochem Z 152:319-344
6. Ter-Pogossian MM, Phelps ME, Hoffman EJ, Mullani NA (1975) A positron-emission transaxial tomograph for nuclear imaging (PETT). Radiology 114(1):89-98
7. Lagadec C, Vlashi E, Della Donna L, Meng Y, Dekmezian C, Kim K, Pajonk F (2010) Survival and self-renewing capacity of breast cancer initiating cells during fractionated radiation treatment. Breast cancer Res 12(1):R13
8. Vlashi E, Kim K, Lagadec C, Donna LD, McDonald JT, Eghbali M, Sayre JW, Stefani E, McBride W, Pajonk F (2009) In vivo imaging, tracking, and targeting of cancer stem cells. J Natl Cancer Inst 101(5):350-359
9. Pollard SM, Yoshikawa K, Clarke ID, Danovi D, Stricker S, Russell R, Bayani J, Head R, Lee M, Bernstein M et al (2009) Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell 4(6):568-580
10. Amo T, Yadava N, Oh R, Nicholls DG, Brand MD (2008) Experimental assessment of bioenergetic differences caused by the common European mitochondrial DNA haplogroups H and T. Gene 411(1-2):69-76
11. Lagadec C, Vlashi E, Della Donna L, Dekmezian C, Pajonk F (2012) Radiation-induced reprogramming of breast cancer cells. Stem cells 30(5):833-844
12. Lagadec C, Vlashi E, Alhiyari Y, Phillips TM, Dratver MB, Pajonk F (2013) Radiation-induced notch signaling in breast cancer stem cells. Int J Radiat Oncol Biol Phys 87(3):609
13. Vlashi E, Lagadec C, Chan M, Frohnen P, McDonald AJ, Pajonk F (2013) Targeted elimination of breast cancer cells with low proteasome activity is sufficient for tumor regression. Breast Cancer Res Treat 141(2):197-203
14. Conley SJ, Gheordunescu E, Kakarala P, Newman B, Korkaya H, Heath AN, Clouthier SG, Wicha MS (2012) Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia. Proc Natl Acad Sci USA 109(8):2784-2789
15. Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D, Pilotti S, Pierotti MA, Daidone MG (2005) Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 65(13):5506-5511 (Pubitemid 40911148)
16. Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A, Gerszten RE, Wei R, Fleming MD, Schreiber SL, Cantley LC (2008) The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452(7184):230-233 (Pubitemid 351380249)
17. Christofk HR, Vander Heiden MG, Asara JM, Cantley LC (2008) Pyruvate kinase M2 is a phosphotyrosine-binding protein. Nature 452(7184):181-186 (Pubitemid 351380242)
18. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4):663-676 (Pubitemid 44233629)
19. Moon JS, Kim HE, Koh E, Park SH, Jin WJ, Park BW, Park SW, Kim KS (2011) Kruppel-like factor 4 (KLF4) activates the transcription of the gene for the platelet isoform of phosphofructokinase (PFKP) in breast cancer. J Biol Chem 286(27):23808-23816
20. Vlashi E, Lagadec C, Vergnes L, Matsutani T, Masui K, Poulou M, Della Donna L, Evers P et al (2011) Metabolic state of glioma stem cells and nontumorigenic cells. Proc Natl Acad Sci USA 108(38):16062-16067
21. Warburg O (1924) On the metabolism of carcinoma cells. Biochem Z 152(309-344):309
22. Lagadinou ED, Sach A, Callahan K, Rossi RM, Neering SJ, Minhajuddin M, Ashton JM, Pei S, Grose V, O'Dwyer KM et al (2013) BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells. Cell Stem Cell 12(3):329-341
23. Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324(5930):1029-1033
24. Zhang WC, Shyh-Chang N, Yang H, Rai A, Umashankar S, Ma S, Soh BS, Sun LL, Tai BC, Nga ME et al (2012) Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis. Cell 148(1-2):259-272
25. Morfouace M, Lalier L, Bahut M, Bonnamain V, Naveilhan P, Guette C, Oliver L, Gueguen N, Reynier P, Vallette FM (2012) Comparison of spheroids formed by rat glioma stem cells and neural stem cells reveals differences in glucose metabolism and promising therapeutic applications. J Biol Chem 287(40):33664-33674
26. Menendez JA, Joven J, Cufi S, Corominas-Faja B, Oliveras-Ferraros C, Cuyas E, Martin-Castillo B, Lopez-Bonet E, Alarcon T, Vazquez-Martin A (2013) The Warburg effect version 2.0: metabolic reprogramming of cancer stem cells. Cell Cycle 12(8):1166-1179
27. Feng W, Gentles A, Nair RV, Huang M, Lin Y, Lee CY, Cai S, Scheeren FA, Kuo AH, Diehn M (2014) Targeting unique metabolic properties of breast tumor initiating cells. Stem cells 32(7):1734-1745